Sapna Shah Acquires 20,000 Shares of BioPharma Credit (LON:BPCR) Stock

BioPharma Credit (LON:BPCR - Get Free Report) insider Sapna Shah purchased 20,000 shares of the business's stock in a transaction dated Wednesday, March 27th. The shares were purchased at an average price of GBX 72 ($0.91) per share, with a total value of £14,400 ($18,197.90).

BioPharma Credit Stock Performance

BPCR stock opened at GBX 0.90 ($0.01) on Thursday. The company has a market capitalization of £11.65 million, a price-to-earnings ratio of 6.89 and a beta of 0.21. BioPharma Credit has a fifty-two week low of GBX 0.81 ($0.01) and a fifty-two week high of GBX 0.98 ($0.01). The stock has a fifty day moving average of GBX 0.91 and a 200-day moving average of GBX 0.87.

BioPharma Credit Cuts Dividend

The company also recently declared a dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Thursday, March 28th will be paid a dividend of $0.02 per share. The ex-dividend date is Thursday, March 28th. This represents a dividend yield of 1.97%. BioPharma Credit's payout ratio is 5,384.62%.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

See Also

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at BioPharma Credit?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for BioPharma Credit and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.

Most Read This Month

Recent Articles